Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN Symposium 2018 /
MyPathway study: a novel precision oncology multiple basket trial

25th - 26th Jun 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.07.18
Views: 1187

Dr Mary S. Beattie - Genentech, USA

Dr Beattie speaks with ecancer at the 2018 WIN symposium about the MyPathway study which looks at pre-approved drugs but for new (non-approved) applications.

To do this, MyPathway is a multi-basket study with 6 baskets with a variety of drugs.

She reveals some results from the HER-2 basket as this has gathered the most data thus far, and talks about potential new combinations which could be investigated.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation